Lithium Orotate 2 — Class III food recall H-0447-2025
Terminated recall by GMP Laboratories of America Inc, reported 2025-08-20, distributed in CA, OK. Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.
| Recall number | H-0447-2025 |
|---|---|
| Product type | Food |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | GMP Laboratories of America Inc, Anaheim, CA, United States |
| Recall initiated | 2025-06-24 |
| Classified | 2025-08-08 |
| Reported by FDA | 2025-08-20 |
| Terminated | 2026-02-24 |
| Distributed | CA, OK |
| Quantity | 185,482 capsules |
| Reason classes | specification failure |
| Lot numbers | 21108, 21822, 22649 |
Product
Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X002T4OPLL 10 mg UPC#: X0031AXVE9
Reason for recall
Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/H-0447-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.